Literature DB >> 24355045

The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.

Jason M Franasiak1, Eric J Forman2, Kathleen H Hong2, Marie D Werner2, Kathleen M Upham3, Nathan R Treff2, Richard T Scott2.   

Abstract

OBJECTIVE: To determine the relationship between the age of the female partner and the prevalence and nature of human embryonic aneuploidy.
DESIGN: Retrospective.
SETTING: Academic. PATIENT(S): Trophectoderm biopsies. INTERVENTION(S): Comprehensive chromosomal screening performed on patients with blastocysts available for biopsy. MAIN OUTCOME MEASURE(S): Evaluation of the impact of maternal age on the prevalence of aneuploidy, the probability of having no euploid embryos within a cohort, the complexity of aneuploidy as gauged by the number of aneuploid chromosomes, and the trisomy/monosomy ratio. RESULT(S): Aneuploidy increased predictably after 26 years of age. A slightly increased prevalence was noted at younger ages, with >40% aneuploidy in women 23 years and under. The no euploid embryo rate was lowest (2% to 6%) in women aged 26 to 37, was 33% at age 42, and was 53% at age 44. Among the biopsies with aneuploidy, 64% involved a single chromosome, 20% two chromosomes, and 16% three chromosomes, with the proportion of more complex aneuploidy increasing with age. Finally, the trisomy/monosomy ratio approximated 1 and increased minimally with age. CONCLUSION(S): The lowest risk for embryonic aneuploidy was between ages 26 and 30. Both younger and older age groups had higher rates of aneuploidy and an increased risk for more complex aneuploidies. The overall risk did not measurably change after age 43. Trisomies and monosomies are equally prevalent.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comprehensive chromosomal screening; IVF; embryonic aneuploidy; preimplantation genetic screening; trophectoderm biopsy

Mesh:

Year:  2013        PMID: 24355045     DOI: 10.1016/j.fertnstert.2013.11.004

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  194 in total

Review 1.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

2.  Screening Human Embryos for Polygenic Traits Has Limited Utility.

Authors:  Ehud Karavani; Or Zuk; Danny Zeevi; Nir Barzilai; Nikos C Stefanis; Alex Hatzimanolis; Nikolaos Smyrnis; Dimitrios Avramopoulos; Leonid Kruglyak; Gil Atzmon; Max Lam; Todd Lencz; Shai Carmi
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

3.  Mathematical modeling of human oocyte aneuploidy.

Authors:  Katarzyna M Tyc; Rajiv C McCoy; Karen Schindler; Jinchuan Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

4.  Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort.

Authors:  Elie Hobeika; Sonali Singh; Shaveta Malik; Eric S Knochenhauer; Michael L Traub
Journal:  J Assist Reprod Genet       Date:  2017-06-21       Impact factor: 3.412

5.  Chromosomal abnormalities in products of conception of first-trimester miscarriages detected by conventional cytogenetic analysis: a review of 1000 cases.

Authors:  Larysa Y Pylyp; Lyudmyla O Spynenko; Nataliya V Verhoglyad; Anna O Mishenko; Dmytro O Mykytenko; Valery D Zukin
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

6.  Cumulus-corona gene expression analysis combined with morphological embryo scoring in single embryo transfer cycles increases live birth after fresh transfer and decreases time to pregnancy.

Authors:  T Adriaenssens; I Van Vaerenbergh; W Coucke; I Segers; G Verheyen; E Anckaert; M De Vos; J Smitz
Journal:  J Assist Reprod Genet       Date:  2019-01-09       Impact factor: 3.412

7.  Next Generation Sequencing-Based Comprehensive Chromosome Screening in Mouse Polar Bodies, Oocytes, and Embryos.

Authors:  Nathan R Treff; Rebecca L Krisher; Xin Tao; Heather Garnsey; Chelsea Bohrer; Elena Silva; Jessica Landis; Deanne Taylor; Richard T Scott; Teresa K Woodruff; Francesca E Duncan
Journal:  Biol Reprod       Date:  2016-02-24       Impact factor: 4.285

8.  Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.

Authors:  Bettina Toth; Dunja Maria Baston-Büst; Hermann M Behre; Alexandra Bielfeld; Michael Bohlmann; Kai Bühling; Ralf Dittrich; Maren Goeckenjan; Katharina Hancke; Sabine Kliesch; Frank-Michael Köhn; Jan Krüssel; Ruben Kuon; Jana Liebenthron; Frank Nawroth; Verena Nordhoff; Germar-Michael Pinggera; Nina Rogenhofer; Sabine Rudnik-Schöneborn; Hans-Christian Schuppe; Andreas Schüring; Vanadin Seifert-Klauss; Thomas Strowitzki; Frank Tüttelmann; Kilian Vomstein; Ludwig Wildt; Tewes Wischmann; Dorothea Wunder; Johannes Zschocke
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-12-11       Impact factor: 2.915

9.  Euploidy in relation to blastocyst sex and morphology.

Authors:  Ange Wang; Jonathan Kort; Barry Behr; Lynn M Westphal
Journal:  J Assist Reprod Genet       Date:  2018-07-20       Impact factor: 3.412

10.  Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.

Authors:  Katherine A Green; Marie D Werner; Jason M Franasiak; Caroline R Juneau; Kathleen H Hong; Richard T Scott
Journal:  J Assist Reprod Genet       Date:  2015-08-18       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.